CRT Capital Upgrades Tenet Healthcare (THC) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Deutsche Bank Reiterates Buy on Tenet Healthcare (THC), Raises PT
March 8, 2013 12:46 PM ESTDeutsche Bank today reiterated a Buy rating on Tenet Healthcare (NYSE: THC) and raised its price target to $46.00 (from $43.00). Analysts said Tenet's outlook remains good an visibility is sold.
"We continue to believe THC has solid visibility into its 2013 EBITDA growth," said analyst... More
